FindTrial
Sign In

Management and screening of portal hypertension in hepatocellular carcinoma

Management and screening of portal hypertension in hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084630
Enrollment
Unknown
Registered
2024-05-21
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma with portal hypertension

Interventions

Hepatologists, gastroenterologists, digestive oncologists, interventional hepatologists:no-intervention

Sponsors

Union Hospital of Tongji Medical College; Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Hepatologists, gastroenterologists, digestive oncologists, interventional hepatologists

Exclusion criteria

Exclusion criteria: hepatologists, gastroenterologists, digestive oncologists, interventional hepatologists under 18 years of age or over 70 years of age

Design outcomes

Primary

MeasureTime frame
Primary prevention strategy of portal hypertension in hepatocellular carcinoma;screening rate of portal hypertension in hepatocellular carcinoma ;Secondary prevention strategy of portal hypertension in hepatocellular carcinoma;—

Secondary

MeasureTime frame
The treatment of esophageal and gastric varices bleeding in hepatocellular carcinoma ;The time of esophageal and gastric varices bleeding in hepatocellular carcinoma ;—

Countries

china

Contacts

Public ContactJun Song

Union Hospital of Tongji Medical College; Huazhong University of Science and Technology

song111jun@126.com+86 150 7245 5526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026